Try the modernized beta website. Learn more about the modernization effort.

Key Record Dates Identifier: NCT04345367
Brief Title: Study of Abrocitinib Compared With Dupilumab in Adults With Moderate to Severe Atopic Dermatitis on Background Topical Therapy

First Submitted : March 27, 2020
First Submitted that Met QC Criteria : April 10, 2020
First Posted : April 14, 2020

Last Update Submitted that Met QC Criteria : January 5, 2022
Last Update Posted : January 10, 2022